Literature DB >> 17893755

[The importance of microbiological surveillance networks in monitoring resistant bacteria. RedMIVA].

I Muñoz1, H Vanaclocha, F González.   

Abstract

The increase of the number of antimicrobial resistances is an increasing threat that demands the establishment of a monitoring of the resistance trends by means of systems that facilitate the information like the microbiological surveillance networks. The surveillance resistance system can be active when the strains are analyzed in a reference laboratory or cumulative when microbiology Services asses the antimicrobial susceptibilities of bacterial isolates and summarize on a global report. The microbiological networks allow to realize studies accumulated of a wide number of microorganisms and antimicrobial in a simple way, in real time and coming to details of geographical area delimited by the user. In the Comunitat Valenciana, the Microbiologica surveillance network of the Comunitat Valenciana (RedMIVA) gathers the antibiograms realized in the hospitals of the Comunitat, centralizes the information and spreads the results analyzed to the selected users. The experience has demonstrated that the integration of the hospitals can be initially costly, but once integrated all the hospitals, the yield of the information overcomes the effort of the implementation. By means of simple consultations it is possible to have the information of resistances of the whole Community.

Mesh:

Year:  2007        PMID: 17893755

Source DB:  PubMed          Journal:  Rev Esp Quimioter        ISSN: 0214-3429            Impact factor:   1.553


  3 in total

1.  Antimicrobial resistance in more than 100,000 Escherichia coli isolates according to culture site and patient age, gender, and location.

Authors:  José Miguel Sahuquillo-Arce; María Selva; Hèctor Perpiñán; Miguel Gobernado; Carmen Armero; Antonio López-Quílez; Francisco González; Hermelinda Vanaclocha
Journal:  Antimicrob Agents Chemother       Date:  2011-01-10       Impact factor: 5.191

2.  Empirical monotherapy with meropenem or combination therapy: the microbiological point of view.

Authors:  P Garcinuño; M Santibañez; L Gimeno; A Sánchez-Bautista; J Coy; J Sánchez-Paya; V Boix; E Merino; J Portilla; J C Rodríguez
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-08-09       Impact factor: 3.267

3.  Etiology of bloodstream infections at a population level during 2013-2017 in the Autonomous Community of Valencia, Spain.

Authors:  L Ruiz-Azcona; M Santibañez; A Gimeno; F J Roig; H Vanaclocha; M P Ventero; V Boix; J Sánchez-Payá; J Portilla-Sogorb; E Merino; J C Rodríguez
Journal:  Rev Esp Quimioter       Date:  2020-04-29       Impact factor: 1.553

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.